In Re MRU Holdings Securities Litigation, 769 F. Supp. 2d 500

This is a putative class action alleging MRU Holdings and related parties violated Exchange Act provisions via false/omitted disclosures about auction rate securities (ARS) and related securitizations during 2007-2008.
Plaintiffs Gianoukis and Borkowski purchased MRU common stock in May 2008, after ARS market deterioration, asserting fraud and control-person claims against MRU officers, Merrill Lynch, and Bagell.
MRU securitized its student loans in June 2007 (MRU Trust), generating substantial revenue and creating a Residual Interest whose fair value MRU disclosed depended on judgment and assumptions.
Plaintiffs allege MRU and Merrill manipulated ARS auctions and understated future funding costs, inflating MRU’s stock price during the Class Period.
MRU disclosed ARS risks and sensitivity in its 2007-2008 filings, including potential impairment and reliance on securitization markets, but Plaintiffs claim disclosures were inadequate or misleading.
MRU announced a July 2008 securitization at a discount and later paused loan origination in September 2008; MRU filed for Chapter 7 bankruptcy in February 2009.

Issue	Plaintiff's Argument	Defendant's Argument	Held
Whether MRU/Individual Defendants made misstatements/omissions about Residual Interest	SAC alleges undisclosed risks and inflated Residual Interest.	Disclosures detailed assumptions; statements not false or misleading.	No misstatements shown; disclosures disclosed risks; claims fail.
Whether Merrill is liable as a secondary actor for 10b-5	Merrill owed a disclosure duty and engaged in deceptive ARS practices.	No fiduciary duty to MRU investors; inadequate particularity against Merrill.	No duty or articulate misstatement by Merrill; no 10b-5 liability.
Whether Merrill engaged in market manipulation under 10b-5(a)/(c)	Merrill manipulated ARS auctions by propping bids and hiding illiquidity.	Disclosures on Merrill’s website preclude manipulation claim; market fully disclosed.	Market manipulation claim dismissed as a matter of law.
Whether the plaintiffs adequately pleaded scienter for Individual Defendants and Merrill	Defendants had motive and knowledge of unsustainability of ARS model.	Motive was generalized; no concrete evidence of intent; trading during class period not sufficient.	No strong inference of scienter; claims fail.
Whether Section 20(a) claims survive	Control-person liability predicated on primary securities violation.	Primary claim fails; secondary claims must be dismissed.	Section 20(a) claims dismissed.

Slayton v. American Express Co., 604 F.3d 758 (2d Cir. 2010) (requires strong inference of scienter; tells standard for Evaluate inference)
Ganino v. Citizens Util. Co., 228 F.3d 154 (2d Cir. 2000) (pleading scienter and misstatement with particularity)
ATSI Communications, Inc. v. Shaar Fund, Ltd., 493 F.3d 87 (2d Cir. 2007) (market manipulation elements and pleading requirements)
IBM Corp. Sec. Litig., 163 F.3d 102 (2d Cir. 1998) (cautionary language and forecasts not actionable as fraud)
Keyspan Sec. Litig., 383 F.Supp.2d 358 (E.D.N.Y. 2003) (nondisclosure of information actually disclosed; pleadings standards)